Shingo Tsujinaka

Tohoku Medical and Pharmaceutical University Hospital

Papers

Total Citations

H-Index

About

Shingo Tsujinaka is a leading surgical oncologist whose research focuses on improving outcomes for patients with biliary tract cancer (BTC), a rare and aggressive malignancy. His work addresses critical challenges in surgical management, particularly the high perioperative mortality associated with hilar cholangiocarcinoma and gallbladder cancer. Tsujinaka’s landmark review, “Current insights and future perspectives of treatment strategies for biliary tract cancer,” synthesizes evidence on how tumor location dictates both malignancy and surgical invasiveness, providing a framework for risk-stratified treatment. By analyzing benchmark cases, he has helped define optimal surgical thresholds and perioperative care protocols, directly contributing to reduced mortality rates in high-risk procedures. His research bridges the gap between surgical technique and oncologic outcomes, offering actionable insights for clinicians managing complex hepatobiliary tumors. With a growing citation impact, Tsujinaka’s work is shaping the next generation of treatment strategies, from refined surgical benchmarks to emerging multimodal therapies. For students and researchers, his studies serve as a critical resource for understanding the nuanced interplay between tumor biology and surgical decision-making in BTC.